Our priority is the safety and wellbeing of our talented staff, CT:IQ members, our stakeholders and their families in the current environment. Following the declaration of the COVID-19 (coronavirus) pandemic, CT:IQ have transitioned to a work from home arrangement for the time being. As part of the social distancing measures we are implementing, we now have an emphasis on virtual, rather than face-to-face interactions. We will be conducting all meetings by video conferencing wherever possible or phone.
CT:IQ was scheduled to present at various conferences and events in March and over the coming months. We will instead provide a range of interactive webinars related to current and future clinical trial improvement projects shortly. These will be live streamed and housed on our website as a resource.
In light of COVID-19, now, more than ever, clinical trials are essential to ensure advancements reach those that need them quickly. Therefore, it is critical our work continues to enable efficient, effective and patient-centred clinical trials.
To the CT:IQ community, it’s important to stay in touch virtually so reach out to us anytime, stay safe and be kind to one another.
CT:IQ Programme Director